Immunogenicity and predictors of response to a single dose trivalent seasonal influenza vaccine in multiple sclerosis patients receiving disease‐modifying therapies

AIMS: To evaluate the immunogenicity and safety of a seasonal influenza vaccine in a cohort of multiple sclerosis (MS) patients receiving different immunomodulating/immunosuppressive therapies and assess predictors of immune response. METHODS: A prospective, multicenter, non‐randomized observational...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:CNS Neurosci Ther
Auteurs principaux: Metze, Christoph, Winkelmann, Alexander, Loebermann, Micha, Hecker, Michael, Schweiger, Brunhilde, Reisinger, Emil Christian, Zettl, Uwe Klaus
Format: Artigo
Langue:Inglês
Publié: John Wiley and Sons Inc. 2018
Sujets:
Original Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6488907/
https://ncbi.nlm.nih.gov/pubmed/30044050
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cns.13034
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires